Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, participants with psoriasis vulgaris and chronic urticaria chose Chinese herbal medicine due to beliefs about its safety and effectiveness in preventing relapse, although convenience and clinical evidence remain important considerations.

The study reported a 7.80% prevalence of scarring alopecia in Chinese SLE patients and identified several risk factors, including mucocutaneous lesions and high disease activity, while renal and cardio-respiratory involvements were negatively associated with it.

This study examined Chinese adult patients' discussions on social media about JAK inhibitors for alopecia areata, highlighting significant interest in these treatments but also concerns about efficacy, relapse, side effects, and the emotional impact of the condition.

This study found that 7.80% of Chinese patients with systemic lupus erythematosus experienced scarring alopecia, with certain disease characteristics and treatments influencing its prevalence.

Generalized vitiligo in Chinese patients is linked to other autoimmune diseases, especially in familial cases.

This study examined Chinese patients with alopecia areata and found significant impairment in quality of life, common use of immunomodulatory drugs and supplements, and a 72.9% recovery rate with recurrence, highlighting unmet treatment needs.

This study observed that Chinese patients with alopecia totalis or universalis had an earlier onset, longer duration, and more severe impact on quality of life compared to those with patchy alopecia areata.

This review suggests that Chinese herbal medicine may help reduce side effects of chemotherapy in breast cancer patients, but a lack of high-quality trials limits confidence in this finding.

This study reported that 7.80% of systemic lupus erythematosus patients experienced scarring alopecia, with mucocutaneous lesions and certain autoantibodies identified as risk factors, and some organ involvements and immunosuppressants as protective factors.

In this study, finasteride was found to be more effective than 5% minoxidil for treating male androgenetic alopecia in Chinese patients, with combination therapy showing the greatest improvement.

The CSTAR registry, the largest in China for SLE, reports more than 25,000 patients registered since 2009, detailing demographics, clinical characteristics, and providing data for future studies.

This study found that Chinese female patients with systemic autoimmune diseases treated intravenously with cyclophosphamide were more likely to experience gastrointestinal discomfort, myelosuppression, and alopecia.

In this study, BeauTop treatment significantly increased hair growth in people with androgenetic alopecia compared to placebo, showing effectiveness without adverse reactions.

This study found that critically ill pulmonary patients with deficiency syndrome were at a higher risk of developing type 2 myocardial infarction than those with phlegm syndrome.

This study found that dermatoscopy is useful for diagnosing and assessing primary cicatricial alopecias in Chinese patients, with alopecia mucinosa having a distinct feature of patulous follicular openings.

This study found that among Chinese males with male androgenic alopecia, combination therapy using topical minoxidil and nano-microneedle-assisted fibroblast growth factor significantly improved hair density, diameter, and follicular unit density over 16 weeks, outperforming individual treatments.

This study found that three-quarters of patients experienced hair loss following laparoscopic sleeve gastrectomy, with female gender, preoperative serum folic acid, and percent excess weight loss as significant risk factors.

In this study, family history of androgenetic alopecia was associated with earlier onset and increased severity of hair loss in men, but had no impact on treatment effectiveness.

This study found that in Chinese women with PCOS, pretreatment with ethinylestradiol/cyproterone acetate was associated with a lower risk of gestational diabetes, pregnancy-induced hypertension, and premature delivery compared to those without pretreatment.

In this study, novel mutations in the BTD gene were identified in a patient with profound biotinidase deficiency, highlighting the importance of biotinidase activity measurement and mutation analysis for early diagnosis.

In this study, researchers found that the original four-factor model of causal illness attributions in the IPQ-R did not fit a Chinese sample, and instead identified a two-factor model focusing on psychological attributions and risk factors.

LIPH mutations cause woolly hair in some Chinese people.

In this study, female pattern hair loss in Chinese Han patients was characterized by decreased hair density and shaft diameter, with minor gender differences and the vertex most affected.

Small Botox dose effectively treats hair loss in Chinese men.

This study suggests that genetic variations in the AMH signal pathway may be linked to susceptibility and phenotype variations in PCOS among women with insulin resistance.

This study found that serum bone metabolic markers with mild changes are interdependently related to traditional Chinese medicine syndromes in patients with chronic kidney disease-related bone disorders.

In this phase I study, CT-707, a new ALK inhibitor, showed a 77% response rate among Chinese patients with advanced ALK-rearranged non-small cell lung cancer, suggesting clinical effectiveness despite some adverse events like diarrhea and liver enzyme elevation.

This study concluded that qianliekang combined with liuweidihuangwan is a more economical treatment for benign prostatic hyperplasia compared to finasteride plus tamsulosin.

This letter reports a homozygous missense mutation in the LIPH gene causing autosomal recessive hypotrichosis simplex in a Chinese patient.

This case study reports a 36-year-old man with KID syndrome caused by an N14Y GJB2 mutation, expanding the mutation spectrum of this condition in the Chinese population.